<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04614402</url>
  </required_header>
  <id_info>
    <org_study_id>2019-11</org_study_id>
    <nct_id>NCT04614402</nct_id>
  </id_info>
  <brief_title>Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System</brief_title>
  <acronym>TriCLASP</acronym>
  <official_title>Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post-Market Clinical Follow up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a postmarket clinical follow up study on the safety and effectiveness of the Edwards&#xD;
      PASCAL Transcatheter Valve Repair System in transcatheter tricuspid valve repair.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this clinical study are to collect data on the safety and effectiveness of&#xD;
      the PASCAL System in improving TR, functional status, and quality of life in a post-market&#xD;
      setting.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2021</start_date>
  <completion_date type="Anticipated">March 15, 2028</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with major adverse events (MAE rates)</measure>
    <time_frame>30 days</time_frame>
    <description>The primary safety endpoint is the proportion of patients with major adverse events (MAEs) at 30 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in tricuspid regurgitation severity (scale of 0-5) by echocardiography</measure>
    <time_frame>Discharge: defined as discharge or 7 days post-procedure, whichever comes first</time_frame>
    <description>Reduction in TR severity as assessed by TEE pre and post-implant in the procedure room. TR severity compared to baseline will be assessed by TR grade at each follow-up interval.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume overload assessed by serial measurements</measure>
    <time_frame>baseline, 30 days, 6 months, 12 months, annually up to 5 years</time_frame>
    <description>Patient edema questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume overload assessed by serial measurements</measure>
    <time_frame>baseline, 30 days, 6 months, 12 months, annually up to 5 years</time_frame>
    <description>Body weight in kilogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume overload assessed by serial measurements</measure>
    <time_frame>baseline, 30 days, 6 months, 12 months, annually up to 5 years</time_frame>
    <description>Edema Assessment (scale 1+ - 4+) grade correspond to mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume overload assessed by serial measurements</measure>
    <time_frame>baseline, 30 days, 6 months, 12 months, annually up to 5 years</time_frame>
    <description>Ankle circumference measurement in cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional class, functional status, and Quality of life as assessed</measure>
    <time_frame>baseline, 30 days, 6 months, 12 months, annually up to 5 years</time_frame>
    <description>NYHA classification (I-IV) grade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional class, functional status, and Quality of life as assessed</measure>
    <time_frame>baseline, 30 days, 6 months, 12 months, annually up to 5 years</time_frame>
    <description>6-Minute Walk Test in meter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional class, functional status, and Quality of life as assessed</measure>
    <time_frame>baseline, 30 days, 6 months, 12 months, annually up to 5 years</time_frame>
    <description>5 Level EQ 5D Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional class, functional status, and Quality of life as assessed</measure>
    <time_frame>baseline, 30 days, 6 months, 12 months, annually up to 5 years</time_frame>
    <description>Kansas City Cardiomyopathy Questionnaire</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Tricuspid Valve Insufficiency</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Edwards PASCAL Transcatheter Valve Repair System</intervention_name>
    <description>The Edwards PASCAL Valve Repair System is indicated for the percutaneous reconstruction of an insufficient tricuspid valve.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients at or over the age of 18 determined to require percutaneous reconstruction of an&#xD;
        insufficient tricuspid valve (TR ≥ 3+) by a Heart Team who assesses patient risk and&#xD;
        anatomic suitability for the procedure.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient is a candidate for transcatheter tricuspid valve repair as determined by a&#xD;
             Heart Team&#xD;
&#xD;
          2. TR grade ≥3+ (5 grade classification)&#xD;
&#xD;
          3. Patient is eligible to receive the PASCAL device per the current approved indications&#xD;
             for use&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Tricuspid valve anatomic contraindications, including previous tricuspid valve&#xD;
             replacement&#xD;
&#xD;
          2. Severe aortic, mitral, and/or pulmonic valve stenosis and/or regurgitation&#xD;
&#xD;
          3. Concurrent medical condition with a life expectancy of less than 12 months in the&#xD;
             judgment of the Investigator&#xD;
&#xD;
          4. Any patient considered to be part of a vulnerable population&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephan Baldus, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herzzentrum Uniklinik Köln, Klinik III für lnnere Medizin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>TMTT Clinical Affairs</last_name>
    <phone>+1 (949) 250</phone>
    <phone_ext>2500</phone_ext>
    <email>TMTT_Clinical@edwards.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm Innere Medizin II</name>
      <address>
        <city>Ulm</city>
        <state>Baden-Wuerttemberg</state>
        <zip>89070</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mirjam Kessler, Dr.</last_name>
      <phone>+49731500</phone>
      <phone_ext>45064</phone_ext>
      <email>mirjam.kessler@uniklinik-ulm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg Klinik für Kardiologie, Angiologie, Pneumologie</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philip Raake, Prof. Dr.</last_name>
      <phone>+49622156</phone>
      <phone_ext>8676</phone_ext>
      <email>philip.raake@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen Innere Medizin III - Kardiologie und Angiologie</name>
      <address>
        <city>Tübingen</city>
        <state>Baden-Württemberg</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Geisler, Prof. Dr.</last_name>
      <phone>+497071 29</phone>
      <phone_ext>84405</phone_ext>
      <email>tobias.geisler@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik I- Campus Grosshadern</name>
      <address>
        <city>München</city>
        <state>Bavaria</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joerg Hausleiter, Prof. Dr.</last_name>
      <phone>+49 894400</phone>
      <phone_ext>72361</phone_ext>
      <email>joerg.hausleiter@med.uni-muenchen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Universitätsklinikum Köln</name>
      <address>
        <city>Köln</city>
        <state>DEU</state>
        <zip>D-50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Baldus, Prof.Dr.</last_name>
      <phone>+ 49 221 478 85455</phone>
      <email>stephan.baldus@uk-koeln.de</email>
    </contact>
    <contact_backup>
      <last_name>Ana Heinrichs</last_name>
      <phone>+49 221 47832417</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen UKGM</name>
      <address>
        <city>Gießen</city>
        <state>Hessen</state>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Nef, Prof. Dr.</last_name>
      <phone>+49641985</phone>
      <phone_ext>42212</phone_ext>
      <email>Holger.Nef@innere.med.uni-giessen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Westdeutsches Herz- und Gefäßzentrum Klinik für Kardiologie und Angiologie</name>
      <address>
        <city>Essen</city>
        <state>Nordrhine Westfalia</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Lüdike, Prof. Dr.</last_name>
      <phone>+492017238</phone>
      <phone_ext>4809</phone_ext>
      <email>peter.luedike@uk-essen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Siegburg</name>
      <address>
        <city>Siegburg</city>
        <state>North Rhine Westphalia,</state>
        <zip>53721</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Boekstegers, Prof. Dr.</last_name>
      <phone>+490224118</phone>
      <phone_ext>2268</phone_ext>
      <email>peter.boekstegers@helios-gesundheit.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW - Bad Oeynhausen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <state>North Rhine Westphalia</state>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kai Friedrich, Dr.</last_name>
      <phone>+495731</phone>
      <phone_ext>973667</phone_ext>
      <email>kpfriedrich@hrz-nrw.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herzzentrum der Universitätsklinik Bonn</name>
      <address>
        <city>Bonn</city>
        <state>North Rhine Westphalia</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Georg Nickenig, Prof. Dr.</last_name>
      <phone>+49228287</phone>
      <phone_ext>15217</phone_ext>
      <email>Georg.Nickenig@ukbonn.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin der Johannes Gutenberg Universität Mainz</name>
      <address>
        <city>Mainz</city>
        <state>Rhineland-Palatinate</state>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan von Bardeleben, Dr.</last_name>
      <phone>+49 6131</phone>
      <phone_ext>172892</phone_ext>
      <email>stephan.von_Bardeleben@unimedizin-mainz.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Heart Centre of the University Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Lurz, Prof. Dr.</last_name>
      <phone>+49341865</phone>
      <phone_ext>1428</phone_ext>
      <email>philipp.lurz@medizin.uni-leipzig.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zentralklinik Bad Berka GmbH</name>
      <address>
        <city>Bad Berka</city>
        <state>Thuringia</state>
        <zip>99437</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Harald Lapp, Prof. Dr.</last_name>
      <phone>+49 36458 51201</phone>
      <email>Harald.Lapp@zentralklinik.de</email>
    </contact>
    <contact_backup>
      <last_name>Kristin Ungethuem</last_name>
      <phone>+49 36458542569</phone>
      <email>Kristin.Ungethuem@zentralklinik.de</email>
    </contact_backup>
    <investigator>
      <last_name>Harald Lapp, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UKE Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edith Lubos, Dr.</last_name>
      <phone>+49407410</phone>
      <phone_ext>53979</phone_ext>
      <email>e.lubos@uke.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kath. Marienkrankenhaus Hamburg gGmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>22087</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Schäfer, Prof.Dr.</last_name>
      <phone>+49 402546</phone>
      <phone_ext>2102</phone_ext>
      <email>schaefer.kardiologie@marienkrankenhaus.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Heart Center Lübeck</name>
      <address>
        <city>Lübeck</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ingo Eitel, Prof.Dr.</last_name>
      <email>Ingo.Eitel@uksh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Inselspital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabien Praz, Prof.</last_name>
      <phone>+4131632</phone>
      <phone_ext>8350</phone_ext>
      <email>Fabien.Praz@insel.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 25, 2020</study_first_submitted>
  <study_first_submitted_qc>October 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2020</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

